Working Group on a New Grand Bargain for Antimicrobial Procurement
June 27, 2022
While there have been high-level commitments from the World Health Assembly, the United Nations General Assembly (UNGA), the G20, and the G7 to tackle AMR, there has yet to be a fundamental change in how we purchase antimicrobials, or an international approach to improving access, fostering innovati...
The ‘Learning at Scale’ Advisory Group
October 08, 2019
Learning outcomes are low and instruction is poor in many countries in the Global South. Improving learning outcomes has proven to be difficult, although the number of successful programs is growing. The effective examples have seldom been implemented at large scale, however; and the large-scale suc...
The Future of US Government Development Assistance to Fragile States
August 13, 2018
Working Group on the Future of Global Health Procurement
July 31, 2017
Many low-and lower-middle-income countries currently procure a large portion of their health commodities through centralized, donor-managed procurement mechanisms, and often at subsidized prices or as donations. Over the next several decades, however, the landscape of global health procurement will ...
Drug Resistance Working Group (November 2007 – June 2010)
September 10, 2014
Value for Money: An Agenda for Global Health Funding Agencies
August 25, 2014
As international commitments become more ambitious and aid resources become increasingly constrained, global health funding agencies are seeking to improve the efficiency and impact of their investments. This growing “value for money” (VfM) agenda aims to reduce costs, increase imp...